Andy Stergachis

Professor of Pharmacy, Global Health & Adjunct Professor of Epidemiology and Health Services; Associate Dean for Research, Graduate Programs and New Initiatives

CHOICE Faculty, Department of Pharmacy, Institute for Innovative Pharmacy Practice, Office of the Dean, Pharmacy Faculty, Plein Center in Geriatrics Faculty, School Faculty

Telephone: (206) 221-0703


Office Location: H362B Box 357631 1959 NE Pacific St Seattle, WA 98195

Website: Global Medicines Program


  • PhD in Social & Administrative Pharmacy, University of Minnesota
  • MS in Pharmacy Administration, University of Minnesota
  • BPharm Pharmacy, Washington State University

Courses Taught

  • Pharm 581/GH 543: Global Health Pharmacy
  • Pharm 582/GH 590: Global Pharmacovigilance


Andy Stergachis is Professor of Pharmacy and Global Health and Adjunct Professor of Health Services and Epidemiology, Associate Dean, School of Pharmacy, and Director of the Global Medicines Program, University of Washington. He is an author of over 160 peer-reviewed publications in areas such as drug safety, pharmaceutical outcomes, and clinical epidemiology and served as Editor-in-Chief of the Journal of the American Pharmacists Association. He is an elected member of the National Academies of Medicine. He served on the Drug Safety and Risk Management Advisory Committee for the US FDA, Malaria in Pregnancy Consortium Safety Working Group, the Advisory Group to Global Alert and Response for the WHO, the Access and Product Management Advisory Committee for Medicines for Malaria Venture, and the Bill & Melinda Gates Foundation Safety Surveillance Working Group. He is Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, He is a Fellow of the International Society for Pharmacoepidemiology and a Fellow of the American Pharmacists Association.  Since 2010, He has chaired 7 PhD student doctoral dissertation committees (Epidemiology and Pharmacy), mentored postdoctoral trainees, served on numerous graduate student PhD dissertation and MPH thesis committees, and served as advisor to multiple graduate students.

Dr. Stergachis’ research focus is pharmacoepidemiology, global medicines safety, pharmaceutical outcomes research, and public health systems research.   He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries and has developed novel approaches for HIV pharmacovigilance and strengthening pharmacy services in LMICs.  He is currently PI of the University of Washington component of a pharmacovigilance project funded by the Bill & Melinda Gates Foundation. He is the PI of the UW component of a USAID-funded cooperative agreement with Management Sciences for Health on the Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. He is a co-investigator on a project with the Institute for Health Metrics and Evaluation (IHME) on mapping and monitoring the global burden of antimicrobial resistance.  Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.